Showing results (121-130 of 130) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Endocrine Pathology|April 13, 2002
Pathologic features and expression of insulin-like growth factor-2 in adrenocortical neoplasmsL A Erickson, L Jin, T J Sebo, et al.Brain : a Journal of Neurology|April 4, 2013
The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studiesAndrew G B Thompson, Jessica Lowe, Zoe Fox, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 4, 2000
Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroidL A Erickson, L Jin, J R Goellner, et al.Neurology|October 21, 2011
PRION-1 scales analysis supports use of functional outcome measures in prion diseaseS Mead, M Ranopa, G S Gopalakrishnan, et al.Nature Communications|August 10, 2020
A blood miRNA signature associates with sporadic Creutzfeldt-Jakob disease diagnosisPenny J Norsworthy, Andrew G B Thompson, Tze H Mok, et al.The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Pediatric endocrine surgery: a 20-year experience at the Mayo ClinicA Kundel, G B Thompson, M L Richards, et al.Archives of Surgery (Chicago, Ill. : 1960)|June 8, 2000
What prognostic factors are important in duodenal adenocarcinoma?F G Bakaeen, M M Murr, M G Sarr, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 1, 1997
Long-term consequences of intraoperative spillage of bile and gallstones during laparoscopic cholecystectomyD C Rice, M A Memon, R L Jamison, et al.Molecular Psychiatry|March 6, 2021
Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseasesAndrew G B Thompson, Prodromos Anastasiadis, Ronald Druyeh, et al.Mayo Clinic Proceedings|July 25, 2000
Prospective evaluation of Roux-en-Y gastric bypass as primary operation for medically complicated obesityB M Balsiger, F P Kennedy, H S Abu-Lebdeh, et al.Pageof 13